Clinical Trial Update: Precision Medicine Offers Belatacept Monotherapy [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating belatacept monotherapy in transplantation was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Transplantation

Drugs mentioned

• belatacept (belatacept)

Snippet

Sponsor: University of California, San Francisco | Conditions: Transplantation | Phase 4 | Status: WITHDRAWN